TELA Bio, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
TELA Nasdaq 3850 www.telabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TELA Bio, Inc.

Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates - Nov 5th, 2025 5:10 pm
TELA Bio to Announce Third Quarter 2025 Financial Results - Nov 4th, 2025 6:30 am
TELA Bio Appoints William Plovanic to Board of Directors - Nov 3rd, 2025 2:05 pm
United States Breast Reconstruction Market Growth Trends and Forecast Report 2025-2033, Profiles of Mentor Worldwide, AbbVie, Integra, Sientra, Stryker, Establishment Labs, RTI Surgical, TELA Bio - Oct 23rd, 2025 2:52 am
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran - Oct 9th, 2025 2:05 pm
Positive Signs As Multiple Insiders Buy TELA Bio Stock - Oct 9th, 2025 5:32 am
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Aug 12th, 2025 1:06 am
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - Aug 11th, 2025 5:00 pm
TELA Bio Reports Second Quarter 2025 Financial Results - Aug 11th, 2025 2:03 pm
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 8th, 2025 3:00 pm
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates - Aug 7th, 2025 7:10 am
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2025 6:15 am
NeoGenomics (NEO) Meets Q2 Earnings Estimates - Jul 29th, 2025 6:15 am
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference - Jul 23rd, 2025 2:03 pm
TELA Bio to Announce Second Quarter 2025 Financial Results - Jul 21st, 2025 2:03 pm
Breakeven On The Horizon For TELA Bio, Inc. (NASDAQ:TELA) - Jul 2nd, 2025 7:52 am
Aroa Biosurgery Ltd (AROAF) (FY25) Earnings Call Highlights: Surpassing Revenue Expectations ... - Jun 7th, 2025 9:01 pm
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jun 6th, 2025 2:05 pm
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair - Jun 3rd, 2025 2:05 pm
TELA Bio Appoints Jeffrey Blizard as President - Jun 2nd, 2025 6:30 am